scholarly journals Role of Amritadi Kwath in Tamaka Shwasa (Bronchial Asthma)

2021 ◽  
Vol 07 (10) ◽  
Author(s):  
Dr. Harsha Radhakrishnan ◽  

Tamaka Shwasa is one of the chronic disorders of Pranavaha srotos which occurs by Pratiloma gati of Vata due to obstructed Kapha. Tamaka Shwasa is often correlated with Bronchial Asthma in modern medicine. Asthma is a disease of airways that is characterised by increased responsiveness of the tracheobronchial tree to a variety of stimuli. Keeping these points in view, the clinical study entitled as “Role of Amritadi Kwath in Tamaka Shwasa (Bronchial Asthma)” was been selected. For this 27 patients of Tamaka Shwasa were randomly selected on the basis of inclusion and exclusion criteria from Kayachikitsa O.P.D of Rishikul Campus, UAU, Haridwar. The drug chosen was Amritadi Kwath (with Pippali churna as Anupan) from Chakradatta which was given in a dose of 40 ml twice daily for 45 days. Assessment was done at the interval of 7 days during this period, along with a follow up of 15 days after the completion of trial on the basis of subjective and objective parameters. Appropriate statistical tests were used for obtaining the results. The effect of trial was considered on the basis of percentage relief in the above parameters. Maximum improvement were noted in Sleshma vimokshante labhate sukham (92.31%), Kapha nishtivana (88.46%) and Ushnabhinanditi (84.91%). In overall response, marked improvement was found in 56% patients, moderate improvement in 28% patients, mild improvement in 8% patients and no change in 8% patients. As per the data collected, Amritadi Kwath when given in Tamaka Shwasa was effective in relieving the symptoms in the patients.

2021 ◽  
Vol 11 (12) ◽  
pp. 91-95
Author(s):  
Archana Verma ◽  
Meenu Mishra ◽  
Raju Ninama

Background: Bronchial Asthma is a disease of airways that is characterized by hyper-responsiveness of the tracheobronchial tree to a variety of stimuli resulting in widespread spasmodic narrowing of the airway. According to WHO 2016, Asthma affects 235 million people worldwide, out of which 15-20 million people are from India. In India, the prevalence of self-reported asthma is 2% among women aged 15-49 years and 1% among young women aged 15-19 years as well as men aged 15-49 years as per the latest report. Prevalence of asthma is more in urban areas than rural area as due to smoke, pollution and environmental factor. In Ayurveda Bronchial Asthma has a high resemblance with Tamaka Shwasa which comes under Pranavaha Srotas. It is described in Brihatrayee as well as Laghutrayee. Acharya Charak and Sushruta has given detailed description of Tamaka Shwasa. Aim and Objectives: To study the effect of shwasa kuthar rasa in the management of (bronchial asthma) and to find out an effective Ayurvedic medicine for Tamaka Shwasa (Bronchial Asthma). Material and Methods: For this open clinical study, 10 patients of Tamak Shwasa (bronchial asthma) were registered from OPD of Kayachikitsa department and admitted in IPD of Pt. Khushilal Govt (Auto.) Ayurveda Hospital Bhopal. The patient was treated with Shwasa Kuthar Rasa. Duration of study was 30 days and follow up was done after completion of trial every week for 1 month, assessment was done on the basis of symptomatic relief and increase the range of FEV1 and FVC value after treatment. Observation: yielded symptomatic relief after treatment. The overall effect of the treatment in patient suggested that, there is 87.50 % relief in cough (Kasa), 90.01% relief in dyspnoea (Shwasakashta), 93.37% relief in chest tightness (Urashool) and 74.99% relief in wheezing (Ghurghurak) and value of FEV1 and FVC were increased up to 22.29% & 24.43% after treatment. Conclusion: On the basis of result obtained, it can be concluded that Shwasa Kuthar Rasa can be used as an effective medicine in the management of (Bronchial asthma). Key words: Tamaka Shwasa, Bronchial Asthma, Shwasa Kuthar Rasa.


2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 497.2-497
Author(s):  
J. Arroyo Palomo ◽  
M. Arce Benavente ◽  
C. Pijoan Moratalla ◽  
B. A. Blanco Cáceres ◽  
A. Rodriguez

Background:Musculoeskeletal ultrasound (MSUS) is frequently used in several rheumatology units to detect subclinical inflammation in patients with joint symptoms suspected for progression to inflammatory arthritis (IA). Synovitis grade I (EULAR-OMERACT combined score) is known to be a casual finding in healthy individuals, but studies headed to unravel its possible role on rheumatic diseases are sparse.Objectives:To investigate the correlation between synovitis grade I, and the diagnosis of IA made after a year follow-up period since MSUS findings, in patients of an MSUS-specialized unit of a Rheumatology Department.Methods:We conducted a descriptive, retrospective and unicentric study. 30 patients were selected from the MSUS-specialized unit of our Rheumatology Department from July-18 to January-19. Patients presenting synovitis grade 0 (exclusively), 2 and/or 3 on combined score were excluded. Data collection at baseline included age, sex, immunological profile and previous physical examination to the MSUS findings, as well as the diagnosis made by the rheumatologist in 1-year visit follow-up: dividing the patient sample into two groups: those who were diagnosed with IA and those not. Non-parametric statistical tests for comparing means were used.Results:The mean age was 51,6 years and 70% were females. 6 (20%) patients were diagnosed with inflammatory arthritis after a year follow-up: 2 (4,8%) psoriatic arthritis, 1 (3,3%) undifferentiated arthritis, 1 (3,3%) rheumatoid arthritis, 1 (3,3%) Sjögren’s syndrome. Non-inflammatory arthropathies were also found 24 (80%), of which, 12 (40%) were non-specific arthralgias and 8 (19%) osteoarthritis.In the group of patients who did not developed an IA the mean C-reactive protein (CPR) value was 3,12 mg/L and erythrocyte sedimentation rate (ESR) was 8,2 mm; all of them were rheumatoid factor (RF) positive and ACPA-negative except one patient. 5 (31,3%) patients presented low antinuclear antibodies (ANAs) levels. In those who HLA B-27 and Cw6 were tested (4,25%); both were negative except for one that was HLA B-27 positive. The median number of swollen and painful joint count was 0, and the mean of joints with MSUS involvement was 3,5; the mean involved metacarpophalangeal (MCP) joints was 1,83; proximal interphalangeal (PIP) joints was 1,48 and distal interphalangeal (DIP) joints 0,21.Among the group of patients that developed an IA the mean of CPR and ESR was 9,27 mg/L and 14,17 mm respectively; 2 (33%) patients were RF- positive, and 1 ACPA-positive. ANAs were positive in 3 cases (50%). The median of swollen joint count was 2 and for painful joint count was 0, the median of joints with MSUS involvement was 4,5. The mean of MSUS involvement was for MCP, PIP and DIP joints: 1,67, 2 and 0. Comparing the means of CPR values in the two groups with Student’s t-test we obtained a statistically significant difference (p=0,023). No other significant differences were found.Conclusion:Despite the limitations and possible statistical bias, the presence of MSUS-defined synovitis grade I and elevated CRP levels could be related to further diagnoses of inflammatory arthropathy. Besides, the absence of synovitis in DIP joints might have a diagnostic role. Normal physical exploration and normal levels of CRP might suggest low MSUS value. However, further research is needed to clarify the role of MSUS-defined synovitis grade I.References:[1]D’Agostino MA et al. Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 1: definition and development of a standardized, consensus-based scoring system. RMD Open. 2017;3(1):e000428.[2]Van den Berg R et al. What is the value of musculoskeletal ultrasound in patients presenting with arthralgia to predict inflammatory arthritis development? A systematic literature review. Arthritis Research & Therapy (2018) 20:228.Disclosure of Interests:None declared


Author(s):  
Akshaya Patil

Lifestyle disorders like unhealthy dietary habits, physical habits, disturbed sleep and rest patterns are the principal factors that cause many digestion related disease. Irritable bowel syndrome (IBS) is also one such disease which occurs due to the ingestion of unwholesome diet causing disturbances in Agni. According to Ayurvedic science, this disease can be considered as a Grahani roga. So we may consider IBS as Grahani roga. Various herbal medications and panchakarma (biopurification) procedures are described in the treatment of Grahani roga though there is no reliable medical treatment for IBS in modern medicine; various efforts have been made to overcome this problem by the virtue of Ayurvedic therapy. The present study was done to assess the efficacy of Panchmooladya choorna with Takra(buttermilk) as anupan in Group A(10Patients) and Group B(10Patients)with luke warm water as anupan in management of Grahani roga in total of 20patients.The results of therapy were assessed by various parameters after 1month with follow up of 15days.The result concluded that Panchmooladya choorna with Takra as anupan reduced the symptoms of Grahani rog as compared to Group B.


Blood ◽  
2011 ◽  
Vol 118 (21) ◽  
pp. 3182-3182
Author(s):  
Srila Gopal ◽  
Rao Madhumathi ◽  
Damien R Ashby

Abstract Abstract 3182 Methods: We carried out a prospective study of 167 patients with CKD stages 1 to 4 followed over a two year period. Using a competitive radioimmunoassay, we measured plasma hepcidin at baseline and studied its association to baseline clinical parameters, as well as the development of anemia and need for ESA over a two year follow up period. Exclusion criteria included any erythropoietin stimulating agent (ESA) therapy at baseline. Variables were log transformed to satisfy normality assumptions. Results: Median (P5-P95) Glomerular filtration rate (GFR) was 42 (20–109) ml/min and 45% were anemic at the time of enrollment by KDOQI criteria, 11 % (18/167) having severe anemia. In patients with CKD, Hepcidin was positively correlated with serum iron (Spearmans rho,p:serum iron,0.22,0.005) and negatively correlated to EPO levels (Spearmans rho,p:-0.23,0.003 vss.-0.55,0.002). Hepcidin levels at baseline were not significantly associated with GFR, hemoglobin or CRP, and did not differ according to diabetes or ethnicity. Though Hepcidin levels did not differ by the presence of anemia at baseline, they were significantly higher among patients who developed severe anemia (n=23) at the end of the first year (40 ng/mL vs. 25 ng/mL, p<0.01). A total of 13 patients initiated ESA during follow up; a 2-fold higher hepcidin was associated with a hazard ratio of 2.25 (95% CI 0.89 to 5.62) for the need to initiate ESA therapy (Fig 1), adjusted for GFR. Conclusion: High hepcidin, unrelated to inflammation, is a predictor for the development of anemia and the need for initiation of ESA therapy in CKD patients. The role of Hepcidin as a therapeutic target in the anemia of CKD needs further study. Disclosures: No relevant conflicts of interest to declare.


2019 ◽  
Vol 18 (2) ◽  
pp. 132-135
Author(s):  
Paulina Pisaniak ◽  
Dominika Piękoś ◽  
Katarzyna Bąk ◽  
Patryk Stokłosa ◽  
Dorota Ozga

AbstractSIDS is one of the biggest problems of modern medicine. In the diagnosis of SIDS, we take into account all possible diseases that may be the cause of death, as well as factors indicating an accident or murder. The etiology of SIDS is not yet known. There are several pathogenetic concepts, most of which refer to pathophysiological changes associated with nervous system hypoplasia. The most important risk factors include the effects of tobacco smoke, obstetric history, and incorrect sleep position. The role of risk factors in the pathogenesis of SIDS and their interdependence is still the subject of many studies. There are many theories developed on this subject, but none have been supported by scientific research and which is extremely difficult to carry out in this group of newborns. In most cases, medical help finds a newborn already dead, so it is difficult to say what is the main cause or marker of cot death. A considerable success in preventing the onset of sudden infant death syndrome turned out to be educational campaigns for parents - in order to follow up, an information leaflet was prepared with the basic recommendations in the prevention of SIDS. Among the parents of newborn children there are still many controversial opinions about risk factors in the onset of sudden infant death syndrome, the article contains and explains the meaning of individual activities that are considered to predispose to SIDS.


Author(s):  
Smita P. Naram ◽  
Hemang Parekh ◽  
Deepak S. Mahajan ◽  
Ronak D. Naik

Background: The objective of this study was to evaluate the role of Virechana (Arhtrox) followed by Kalbasti (14 in number), Knee dhara and Matrabastiin knee osteoarthritis patients.Methods: From OPD of Ayushakti Ayurveda Pvt. Ltd., 60 Patients suffering from knee Osteoarthritis (Janusandhigatavata) were selected randomly as per the inclusion and exclusion criteria. On the basis of specific criteria prepared. Group-I-(30 patients) received only Ayushakti herbs for Osteoarthritis, viz. Painmuktimj, Painmukti sandhical and Painmukti cream for LA Group-II-(30 patients) received Virechana (Arthrox), KalBastikrama (14 Bastis) and Knee dhara with oil followed by Matrabasti (60 ml) twice a week for 6 months along with Ayushakti herbs for Osteoarthritis. Each participant was in the study for 6 months. The entire study duration was 12 months.Result: About 87 patients were enrolled in the study of which 60 completed the study, 27 patients were drop out of the study, at the different stages of project mainly due to poor follow up. Significant reduction in pain was observed in Groups I and II as compared to the baseline (p <0.001) Pain scale (p <0.001).Conclusion: In this study, good relief was offered in knee joint pain, stiffness and mobility, and daily activities like standing, walking, and climbing. Painmukti mj, Painmukti cream and Painmukti Sandhical tablets are Anti-inflammatory, Analgesic but their efficacy can be increased with Virechana.


2012 ◽  
Vol 9 (1) ◽  
pp. 21-28
Author(s):  
L A Goryachkina ◽  
D V Biteeva ◽  
D S Fomina

In spite of the marked insights of modern medicine into the pathogenesis of bronchial asthma, there is unresolved issue regarding achievement of therapeutic control. Understanding of the immunopathogenesis of the disease resulted in a subdivision into different biological phenotypes due to dominating inflammatory component, characterized by list of biological markers. A role of neutrophilic inflammation in bronchial asthma has been widely discussed in recent studies but is still uncertain. In general, asthma associated with neutrophils tends to be a more aggressive disease with more tissue destruction and airway remodeling; tightly associated with lower response to corticosteroids treatment, moreover, it could be induced by it.


2021 ◽  
Vol 9 (8) ◽  
pp. 1717-1721
Author(s):  
Abhijith N ◽  
Ravindra Bhat K ◽  
Waheeda Banu

Gridhrasi is one among Vataja nanatmaja Vikara characterised by Sthabdhata, Ruk, Toda which radiates from buttock region, lumbar region, thigh, knee, calf muscles and legs. Gridhrasi is of two types viz Vataja and Vata Kaphaja Gridhrasi. Vataja Gridhrasi is characterized by severe pain and Vata Kaphaja Gridhrasi has symptoms viz Tandra, Gaurava and Aruchi. The signs and symptoms of Gridhrasi can be correlated to sciatica of modern medicine. Sciatica is characterized by constant aching pain felt in lumbar region which may radiate to the buttock, thigh, calf and foot and pain is experienced along the sciatic nerve pathway. It was a clinical study with a pre and post design in 30 patients who were diagnosed with Gridhrasi. After examination Laghupanchamoola Kashaya with trivruth choornam was given for 7 days. The assessment criteria were noted before and after treatment and on follow-up. Among the subjective and objective parameters, in the Overall effect of treatment in gridhrasi, out of 30 patients in this study, 15 patients (50%) got Mild effectiveness in shoola, and 15 patients (50%) got Moderate effectiveness in shoola. The overall effect of the treatment was 30.19%. Hence it can be concluded that Laghupanchamoola Kashaya with trivruth choornam is having mild improvement on symptoms of Gridhrasi and shows the long-lasting result. Keywords: Gridhrasi, Sciatica, Laghupanchamoola Kashaya, Trivruth choornam


Author(s):  
Rimpi Majumder ◽  
Aboli Patil ◽  
C. R. Swapnil

The word Shwasa is derived from the root ‘Shwasa Prinane’– which actually means  difficulty in the entry of prana in the pranavaha srotas. Shwasa word  indicates  both  physiological  and  pathological state of  respiration. Tamaka Shwasa is one of the five types of disease shwasa. It is a disease of mainly pranavaha srotas. The sign and Symptoms and etiopathogenesis of Tamaka Shwasa explained in Ayurvedic  literature  have lot of similarities with the disease entity Bronchial Asthma. The goal of this study is to determine the efficacy of the formulation, Haridradi Avaleha in reducing the sign and symptoms of Childhood asthma. A 13 years old boy male Hindu patient from Limda village, Vadodara presented in the OPD of Kaumarbhritya department, Parul Ayurved Hospital, Parul University who presented clinical features of Tamaka Shwasa  was treated by internal Ayurvedic formulation, Haridradi Avaleha showed marked improvement in  the subjective parameters like breathlessness, cough, corzya, awakening in night etc and in objective parameters like ACT(Asthma Control Test), PEFR(Peak Expiratory Flow Rate) some hematological parameters viz. AEC (Absolute Eosinophil Count), ESR (Erythrocyte Sedimentation Rate), WBC Lymphocyte, Neutrophil, discussed here. All subjective and objective parameters were examined during 60 days of follow up-visits, and no instances of the above complaints were reported.


Sign in / Sign up

Export Citation Format

Share Document